Evidence for a Proatherogenic Biochemical Phenotype in Beta Thalassemia Minor and Intermedia

作者: Maria Eliana Lai , Stefania Vacquer , Maria Paola Carta , Alessandra Spiga , Pierluigi Cocco

DOI: 10.1159/000327252

关键词:

摘要: The purpose of this study was to focus on pathophysiological mechanisms linking β-thalassemia intermedia (β-TI) and minor (β-TMI) with cardiovascular risk. Iron status, prooxidant-antioxidant balance lipid profiles in serum, content peripheral blood mononuclear cells (PBMCs) were evaluated 20 β-TMI subjects, 22 β-TI patients 30 nonthalassemic donors. mRNA levels some genes involved the regulation iron cholesterol metabolism also determined. In β-TMI, serum iron, ratio, transferrin saturation erythropoietin higher, while hepcidin lower compared controls. Hepcidin interleukin-1α found be reduced β-TI- β-TMI-PBMCs, those tumor necrosis factor alpha increased. A reduction high-density lipoprotein an accumulation neutral lipids coupled increased acetyl-coenzyme A:cholesterol acyltransferase decreased ester hydrolase PBMCs observed Taken together, these findings provide experimental support for idea that not only but have a proatherogenic biochemical phenotype which may contribute increase their disease

参考文章(33)
M Hashemi, M Yavari, Z Talaei, I Shaygannia, H Taheri, N Amiri, L Moghadas, H Shamsolkottabi, E Shirzadi, H Montazeri, Effect of heterozygous beta-thalassaemia trait on coronary atherosclerosis via coronary artery disease risk factors: a preliminary study. Cardiovascular Journal of Africa. ,vol. 18, pp. 165- 168 ,(2007)
A Cao, L Saba, A Meloni, Y W Kan, V Faà, M C Rosatelli, A Dozy, R Sardu, Molecular characterization of beta-thalassemia in the Sardinian population. American Journal of Human Genetics. ,vol. 50, pp. 422- 426 ,(1992)
Johann W. Auer, Robert Berent, Thomas Weber, Bernd Eber, Iron Metabolism and Development of Atherosclerosis Circulation. ,vol. 106, ,(2002) , 10.1161/01.CIR.0000019984.69119.4F
Ali Taher, Hussain Isma’eel, Ghassan Mehio, Daniela Bignamini, Antonis Kattamis, Eliezer Rachmilewitz, Maria Cappellini, Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran Thrombosis and Haemostasis. ,vol. 96, pp. 488- 491 ,(2006) , 10.1160/TH06-05-0267
T GANZ, Hepcidin--a regulator of intestinal iron absorption and iron recycling by macrophages. Best Practice & Research Clinical Haematology. ,vol. 18, pp. 171- 182 ,(2005) , 10.1016/J.BEHA.2004.08.020
M. GALLERANI, C. SCAPOLI, I. CICOGNANI, A. RICCI, L. MARTINELLI, R. CAPPATO, R. MANFREDINI, G. DALL'ARA, M. FAGGIOLI, P. L. PARESCHI, Thalassaemia trait and myocardial infarction: low infarction incidence in male subjects confirmed Journal of Internal Medicine. ,vol. 230, pp. 109- 111 ,(1991) , 10.1111/J.1365-2796.1991.TB00416.X
P. Lee, H. Peng, T. Gelbart, L. Wang, E. Beutler, Regulation of hepcidin transcription by interleukin-1 and interleukin-6 Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 1906- 1910 ,(2005) , 10.1073/PNAS.0409808102
Raffaella Mariani,, Paola Trombini,, Matteo Pozzi,, Alberto Piperno, Iron Metabolism in Thalassemia and Sickle Cell Disease. Mediterranean Journal of Hematology and Infectious Diseases. ,vol. 1, pp. 2009006- ,(2009) , 10.4084/MJHID.2009.006
Laurelee Osborn, Catherine Hession, Richard Tizard, Cornelia Vassallo, Stefan Luhowskyj, Gloria Chi-Rosso, Roy Lobb, Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. ,vol. 59, pp. 1203- 1211 ,(1989) , 10.1016/0092-8674(89)90775-7